Skip to content
METiS Pharmaceuticals logo — company profile

METiS Pharmaceuticals

Founded 2020 6 employees Series C Total: $336.00M AI, Biopharma +3

General Information

Company Name METiS Pharmaceuticals
Founded Year 2020
Employees 6
Industries AI, Biopharma, Biotechnology +2
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with METiS Pharmaceuticals. To contact METiS Pharmaceuticals, visit metispharmaceuticals.cn.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does METiS Pharmaceuticals compare?

A PDF of METiS Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting METiS Pharmaceuticals soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About METiS Pharmaceuticals

METiS Pharmaceuticals, founded in 2020, is an innovative biotechnology company leveraging artificial intelligence (AI) to drive targeted drug delivery technology for developing more effective drugs. The firm integrates cutting-edge AI technology with traditional pharmaceutical R&D, aiming to accelerate the R&D of innovative drugs in a more efficient and precise way. Its technology platforms support the entire pharmaceutical ecosystem and lead industry innovation. The company secured a notable $100.00M Series C investment on 22 June 2024 from CICC Capital and China Taiping Insurance. The firm operates within the AI, Biopharma, Biotechnology, Medical Devices, and Pharmaceutical industries.

Business keywords: Drug Delivery, Pharmaceutical R&D, Innovation, AI Technology, Precision Medicine, Nucleic Acid Drug Development, Quantum Simulation, Targeted Drug Delivery, Innovative Drug Development, Precision Drug Design, Pharmaceutical Innovation

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series C $100.00M 2
CICC Capital, China Taiping Insurance
22 Jun 2024
Series B $150.00M 8
Lightspeed China Partners, 5Y Capital +6
06 Apr 2022
Series A $86.00M -
13 Dec 2021
Angel Round Undisclosed -
23 Mar 2020

METiS Pharmaceuticals Alternatives & Competitors

View All Alternatives
METiS Pharmaceuticals vs
Spirea
Spirea United Kingdom

Elevating the Therapeutic Potential of ADCs in Cancer and Beyond with Our Unique Multivalent ELIVATE...

Seed
8 employees
Biotechnology, Health Care
METiS Pharmaceuticals vs
Nanoform
Nanoform Finland

Nanoform uses platform technologies to develop innovative nanoparticle medicines, reducing clinical...

Grant
Biotechnology, Pharmaceutical
METiS Pharmaceuticals vs

Putting Patients First, Innovation for All

Series C
1 employees
Biopharma, Biotechnology

FAQ About METiS Pharmaceuticals

METiS is an innovative biotechnology company driven by artificial intelligence (AI) that harnesses targeted drug delivery technology to develop more effective drugs for patients. Through the integration of cutting-edge AI technology and traditional pharmaceutical R&D, METiS aims to accelerate the R&...
METiS Pharmaceuticals was founded in 2020.
METiS Pharmaceuticals operates in AI, Biopharma, Biotechnology, Medical Devices and Pharmaceutical. Its work centres on Drug Delivery, Pharmaceutical R&D, Innovation and AI Technology.
METiS Pharmaceuticals has approximately 6 employees.
METiS Pharmaceuticals has completed 4 funding rounds, raising a total of $336.00M. The latest funding stage is Series C.
Top alternatives and competitors to METiS Pharmaceuticals include Spirea, Nanoform, Beihai Biotech, Rongcan Bio, Evox Therapeutics Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
METiS Pharmaceuticals and Spirea are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for METiS Pharmaceuticals, https://bouncewatch.com/company/metis-pharmaceuticals, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout